newsfilter
← Latest News
GlobeNewswire·

Purple Biotech Announces New Data from CAPTN-3 Platform Tri-specific IM1240

Data, generated in the lab of Dr. Amir Horowitz of the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, demonstrated that all tested patient-derived tumor samples (n=7) responded to IM1240 treatment